RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil
← catalyst calendarNCT06491862 · readout in 134 d
Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
250estimated
Sites
11
Country
Brazil
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-07-25 | actual | When the study began enrolling |
| Primary completion | 2026-12-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2024-07-09 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-22 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Non-squamous Non-Small Cell Lung Cancer
Primary outcomes
what the primary-completion date above is the date OFDescribe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 21th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 21th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe of the population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Describe the patient population and treatment patterns
measured between January 1st 2017 and December 31th 2024
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed